Injectable Nanoparticulate Olanzapine Formulations

Patent No. EP1827374 (titled "Injectable Nanoparticulate Olanzapine Formulations") was filed by Alkermes Pharma Ireland on Nov 16, 2005. The application was issued on Nov 5, 2014.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GENERICS UK	Aug 5, 2015	TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 11, 2018
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Jan 11, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jan 8, 2018
Termination of the opposition proceedings with maintenance of patent
Dec 13, 2017
Advice of delivery
Nov 14, 2017
Advice of delivery
Oct 10, 2017
Advice of delivery
Sep 29, 2017
Advice of delivery
Sep 26, 2017
Acknowledgement of a document
Sep 26, 2017
Acknowledgement of a document
Sep 26, 2017
Decision of the Opposition Division and instruction
Sep 26, 2017
Decision rejecting the opposition
Sep 26, 2017
Grounds for the decision (Annex) - opposition
Sep 26, 2017
Internal form - Opposition/addressees
Sep 15, 2017
(Electronic) Receipt
Sep 15, 2017
Letter accompanying subsequently filed items
Sep 15, 2017
Letter regarding the opposition procedure (no time limit)
Sep 14, 2017
Notification concerning the date of oral proceedings
Sep 14, 2017
Notification concerning the date of oral proceedings
Sep 5, 2017
Brief communication - Opposition proceedings
Aug 30, 2017
(Electronic) Receipt
Aug 30, 2017
Letter accompanying subsequently filed items
Aug 30, 2017
Withdrawal of a request for oral proceedings
Aug 17, 2017
Brief communication - Opposition proceedings
Aug 10, 2017
(Electronic) Receipt
Aug 10, 2017
Amended claims with annotations
Aug 10, 2017
Claims
Aug 10, 2017
Letter accompanying subsequently filed items
Aug 10, 2017
Letter regarding the opposition procedure (no time limit)
Aug 9, 2017
Brief communication - Opposition proceedings
Aug 1, 2017
(Electronic) Receipt
Aug 1, 2017
Letter accompanying subsequently filed items
Mar 15, 2017
Brief communication - Opposition proceedings
Mar 10, 2017
(Electronic) Receipt
Mar 10, 2017
Letter accompanying subsequently filed items
Mar 10, 2017
Request for interpreters during oral proceedings
Mar 9, 2017
Advice of delivery
Feb 22, 2017
Notification concerning the date of oral proceedings
Feb 22, 2017
Notification concerning the date of oral proceedings
Feb 17, 2017
Brief communication - Opposition proceedings
Feb 15, 2017
Advice of delivery
Feb 14, 2017
(Electronic) Receipt
Feb 14, 2017
Any annexes (other than citation) to an opposition letter
Feb 14, 2017
Letter accompanying subsequently filed items
Feb 14, 2017
Oral proceedings: Request for postponement
Feb 3, 2017
Advice of delivery
Feb 2, 2017
Advice of delivery
Jan 30, 2017
Acknowledgement of a document
Jan 30, 2017
Acknowledgement of a document
Jan 30, 2017
Annex to the communication - opposition
Jan 30, 2017
Information concerning oral proceedings
Jan 30, 2017
Preparation for oral proceedings
Jan 30, 2017
Summons to attend oral proceedings
Jan 30, 2017
Summons to attend oral proceedings
May 31, 2016
Brief communication - Opposition proceedings
May 11, 2016
(Electronic) Receipt
May 11, 2016
Any annexes (other than citation) to an opposition letter
May 11, 2016
Letter regarding the opposition procedure (no time limit)
May 11, 2016
Patent document cited during the opposition procedure
May 11, 2016
Reply of the patent proprietor to the notice(s) of opposition
Mar 17, 2016
Brief communication - Opposition proceedings
Mar 17, 2016
Grant of extension of time limit (opposition procedure)
Mar 11, 2016
(Electronic) Receipt
Mar 11, 2016
Letter regarding the opposition procedure (no time limit)
Mar 11, 2016
Request for extension of time limit
Mar 8, 2016
Brief communication - Opposition proceedings
Mar 8, 2016
Brief communication - Opposition proceedings
Feb 29, 2016
(Electronic) Receipt
Feb 29, 2016
Letter regarding the opposition procedure (no time limit)
Feb 29, 2016
Request for extension of time limit
Jan 20, 2016
Brief communication - Opposition proceedings
Jan 20, 2016
Grant of extension of time limit (opposition procedure)
Jan 8, 2016
(Electronic) Receipt
Jan 8, 2016
Any annexes (other than citation) to an opposition letter
Jan 8, 2016
Letter regarding the opposition procedure (no time limit)
Sep 9, 2015
Communication of a notice of opposition and request to file observations
Sep 9, 2015
Notice of further oppositions to opponent(s)
Aug 17, 2015
Communication of a notice of opposition - first information to patent proprietor
Aug 5, 2015
(Electronic) Receipt
Aug 5, 2015
Non-patent literature cited during the opposition procedure
Aug 5, 2015
Non-patent literature cited during the opposition procedure
Aug 5, 2015
Non-patent literature cited during the opposition procedure
Aug 5, 2015
Non-patent literature cited during the opposition procedure
Aug 5, 2015
Non-patent literature cited during the opposition procedure
Aug 5, 2015
Notice of opposition
Aug 5, 2015
Notice of opposition
Aug 5, 2015
Patent document cited during the opposition procedure
Aug 5, 2015
Patent document cited during the opposition procedure
Aug 5, 2015
Patent document cited during the opposition procedure
Aug 5, 2015
Patent document cited during the opposition procedure
Nov 5, 2014
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Oct 9, 2014
Decision to grant a European patent
Sep 26, 2014
(Electronic) Receipt
Sep 26, 2014
Filing of the translations of the claims
Sep 26, 2014
Letter accompanying subsequently filed items
Jul 25, 2014
Bibliographic data of the European patent application
Jul 25, 2014
Communication about intention to grant a European patent
Jul 25, 2014
Intention to grant (signatures)
Jul 25, 2014
Intention to grant (signatures)
Jul 25, 2014
Text intended for grant
Jul 14, 2014
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
May 26, 2014
(Electronic) Receipt
May 26, 2014
Description
May 26, 2014
French translation of claims
May 26, 2014
German translation of the claims
May 26, 2014
Letter accompanying subsequently filed items
May 26, 2014
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Mar 14, 2014
Submission concerning representation
Mar 12, 2014
Submission concerning representation
Feb 12, 2014
Bibliographic data of the European patent application
Feb 12, 2014
Communication about intention to grant a European patent
Feb 12, 2014
Intention to grant (signatures)
Feb 12, 2014
Text intended for grant
Jan 23, 2014
Findings upon submissions relating to oral proceedings
Jan 23, 2014
Notification concerning the date of oral proceedings
Jan 23, 2014
Notification concerning the date of oral proceedings
Jan 23, 2014
Notification concerning the date of oral proceedings
Jan 21, 2014
Annex to the communication
Jan 21, 2014
Consultation by telephone/in person
Jan 21, 2014
Result of consultation by telephone/in person
Jan 17, 2014
(Electronic) Receipt
Jan 17, 2014
Amended claims with annotations
Jan 17, 2014
Annex
Jan 17, 2014
Claims
Jan 17, 2014
Findings upon submissions relating to oral proceedings
Jan 17, 2014
Letter accompanying subsequently filed items
Jan 17, 2014
Written submission in preparation to/during oral proceedings
Jan 16, 2014
Annex to the communication
Jan 16, 2014
Consultation by telephone/in person
Jan 16, 2014
Result of consultation by telephone/in person
Jan 14, 2014
Annex to the communication
Jan 14, 2014
Consultation by telephone/in person
Jan 14, 2014
Result of consultation by telephone/in person
Jan 9, 2014
Annex
Jan 9, 2014
Written submission in preparation to/during oral proceedings
Jan 2, 2014
Findings upon submissions relating to oral proceedings
Dec 20, 2013
(Electronic) Receipt
Dec 20, 2013
Amended claims with annotations
Dec 20, 2013
Amended claims with annotations
Dec 20, 2013
Amended claims with annotations
Dec 20, 2013
Authorisation
Dec 20, 2013
Claims
Dec 20, 2013
Claims
Dec 20, 2013
Claims
Dec 20, 2013
Letter accompanying subsequently filed items
Dec 20, 2013
Written submission in preparation to/during oral proceedings
Oct 8, 2013
Communication to designated inventor
Oct 7, 2013
Communication of the registration of a transfer or change of name and/or address
Oct 1, 2013
(Electronic) Receipt
Oct 1, 2013
Annexes in respect of a client data request
Oct 1, 2013
Annexes in respect of a client data request
Oct 1, 2013
Annexes in respect of a client data request
Oct 1, 2013
Letter accompanying subsequently filed items
Oct 1, 2013
Letter concerning the inventor
Oct 1, 2013
Submission concerning a transfer of rights (applicant)
Jul 22, 2013
Advice of delivery
Jul 17, 2013
Advice of delivery
Jul 11, 2013
Acknowledgement of a document
Jul 11, 2013
Annex to a communication
Jul 11, 2013
Annex to the communication
Jul 11, 2013
Preparation for oral proceedings
Jul 11, 2013
Summons to attend oral proceedings
Oct 21, 2011
(Electronic) Receipt
Oct 21, 2011
Amended claims with annotations
Oct 21, 2011
Annex
Oct 21, 2011
Annex
Oct 21, 2011
Annex
Oct 21, 2011
Claims
Oct 21, 2011
Letter accompanying subsequently filed items
Oct 21, 2011
Non-patent literature cited during the examination procedure
Oct 21, 2011
Reply to communication from the Examining Division
Aug 11, 2011
Grant of extension of time limit (examination procedure)
Aug 5, 2011
(Electronic) Receipt
Aug 5, 2011
Letter accompanying subsequently filed items
Aug 5, 2011
Request for extension of time limit to communication from the Examining Division
Apr 13, 2011
Annex to the communication
Apr 13, 2011
Communication from the Examining Division
Nov 23, 2010
Response to enquiry for communication from the Examining Division
Oct 8, 2010
(Electronic) Receipt
Oct 8, 2010
Enquiry as to when a communication from the Examining Division can be expected
Oct 8, 2010
Letter accompanying subsequently filed items
Apr 14, 2008
Submission concerning representation
Feb 1, 2008
(Electronic) Receipt
Feb 1, 2008
Letter accompanying subsequently filed items
Feb 1, 2008
Letter concerning the inventor
Oct 30, 2007
Communication of the registration of a transfer or change of name and/or address
Oct 19, 2007
Request for change of address
Aug 22, 2007
Invitation to indicate correct address of inventor
Aug 9, 2007
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Aug 9, 2007
Amended claims filed after receipt of (European) search report
Aug 9, 2007
Amendments received before examination
Aug 9, 2007
Claims
Aug 9, 2007
Letter accompanying subsequently filed items
Aug 8, 2007
Notification on forthcoming publication of bibliographic data
Jul 26, 2007
Letter which had not been notified
Jul 16, 2007
Communication regarding possible amendment of claims/payment of claims fees
Jun 13, 2007
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jun 13, 2007
Amended claims filed after receipt of (European) search report
Jun 13, 2007
Amendments received before examination
Jun 13, 2007
Claims
Jun 13, 2007
Request for entry into the European phase
Jun 4, 2007
Copy of the international preliminary report on patentability
Mar 30, 2007
Information on entry into European phase
Nov 30, 2006
Copy of the international search report
Nov 30, 2006
International publication of the international search report
Jun 14, 2006
Priority document (electronically transmitted)
May 26, 2006
Published international application - A2

EP1827374

ALKERMES PHARMA IRELAND

Application Number: EP05851701A
Filing Date: Nov 16, 2005
Status: Opposition Rejected; Jan 12, 2018
Publication Date: Nov 5, 2014
External Links: Slate, Register , Google Patents

IP Verse

Injectable Nanoparticulate Olanzapine Formulations

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP1827374